# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: John F. Kennedy (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML023-SYN
- Date: 2026-03-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harlan Prescott, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week review after the dose changes: electrolytes, renin, repeat thyroid tests, and back pain. **S**

## History of present illness

Mr. Kennedy returns six weeks after hydrocortisone was reduced to 10, 5 and 5 mg and fludrocortisone raised to 0.1 mg, and three weeks after the influenza, during which he doubled his hydrocortisone for four days and then went back to his usual dose; the illness settled without vomiting or any emergency. His energy now lasts the day. The salt craving and the lightheadedness on standing have gone. He has gained 2 kg. He feels a little slow and cold in the mornings. He has had six physical therapy sessions; his back aches less and he wears the brace only in the car. **S**

| Element | Detail |
|---|---|
| Replacement | Hydrocortisone 10, 5 and 5 mg; fludrocortisone 0.1 mg; no missed doses |
| Influenza | Settled; stress doses for four days, then back to usual |
| Symptoms | No salt craving or lightheadedness; slight morning slowness and cold |
| Back | Better after six physical therapy sessions; Oswestry 26% |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy lasts the day; weight up 2 kg |
| Cardiovascular | Negative | No lightheadedness, palpitations, or ankle swelling |
| Respiratory | Negative | Cough from the influenza gone |
| Endocrine | Positive | Feels cold and a little slow in the mornings; no constipation |
| Musculoskeletal | Positive | Low back ache, less than before |

5 systems reviewed. **S**

## Current medications

- Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking **S**
- Hydrocortisone 5 mg oral tablet, one tablet by mouth at noon and one at 4 pm **S**
- Fludrocortisone 0.1 mg oral tablet, one tablet by mouth once daily **S**
- Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times a day as needed for back pain **S**
- Levothyroxine 50 mcg oral tablet, one tablet by mouth each morning on an empty stomach **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/74 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 69 kg; BMI 20.6 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.94 mg/dL; eGFR: 112 mL/min/1.73 m²; Plasma renin activity: 2.6 ng/mL/h; TSH: 9.2 mIU/L (high); Free T4: 0.8 ng/dL; Oswestry Disability Index: 26. All results are synthetic.

## Change since baseline

- Sodium: 134 mmol/L (low) at baseline, 139 mmol/L at this visit **S**
- Potassium: 5.2 mmol/L (high) at baseline, 4.4 mmol/L at this visit **S**
- Creatinine: 0.96 mg/dL at baseline, 0.94 mg/dL at this visit **S**
- eGFR: 109 mL/min/1.73 m² at baseline, 112 mL/min/1.73 m² at this visit **S**
- Plasma renin activity: 9.6 ng/mL/h (high) at baseline, 2.6 ng/mL/h at this visit **S**
- TSH: 7.4 mIU/L (high) at baseline, 9.2 mIU/L (high) at this visit **S**
- Free T4: 1 ng/dL at baseline, 0.8 ng/dL at this visit **S**
- Oswestry Disability Index: 32 at baseline, 26 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 69.0 kg |
| Blood pressure lying and standing | 120/76 lying, pulse 74; 116/74 after three minutes standing, pulse 80: no postural drop |
| Skin | Palmar crease pigmentation fading; no signs of glucocorticoid excess |
| Neck | Thyroid slightly firm, not enlarged; no nodules |
| Extremities | No edema; ankle reflexes normal relaxation |
| Back | Forward flexion to the knees; paraspinal tenderness less |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Primary adrenal insufficiency (autoimmune Addison's disease)** (E27.1). Well replaced on 20 mg hydrocortisone and 0.1 mg fludrocortisone: sodium 139, potassium 4.4 mmol/L, creatinine 0.94 mg/dL, plasma renin activity 2.6 ng/mL/h in the upper normal range, no postural drop. He used the sick-day rules correctly during influenza. **S**
   - Continue the same doses.
   - Electrolytes and renin at the nine-month review.
2. **Autoimmune hypothyroidism** (E06.3). TSH 9.2 mIU/L, up from 7.4 two months ago, with free T4 0.8 ng/dL at the lower limit and positive thyroid peroxidase antibodies: autoimmune hypothyroidism, confirmed on repeat, with mild symptoms. As part of an autoimmune polyglandular syndrome it is likely to progress. Glucocorticoid replacement is secure, so thyroid hormone can safely be started (starting it first can bring on an adrenal crisis). Dr. Desai agrees. **S**
   - Start levothyroxine 50 mcg each morning, 30 to 60 minutes before breakfast and apart from calcium or iron.
   - TSH and free T4 in six weeks.
3. **Raised TSH with positive thyroid peroxidase antibodies** (R94.6). Confirmed on repeat and now recorded as autoimmune hypothyroidism; this finding is closed. **S**
   - Followed under autoimmune hypothyroidism.
4. **Influenza A** (J10.1). Resolved without complications. **S**
   - Influenza vaccine again in the autumn.
5. **Chronic low back pain after lumbar disc surgery** (M96.1). Improving with exercise therapy: Oswestry 26% from 32%. **S**
   - Continue physical therapy and swimming.
   - Brace for the car only.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, and signs of under- or over-replacement | Every visit | Completed today | Weight 69.0 kg (up 2.2 kg); energy through the day; no signs of excess |
| Examination | Blood pressure lying and standing | Every visit | Completed today | 120/76 lying, 116/74 standing: no postural drop |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | After any fludrocortisone change, then at least yearly | Completed today | Six weeks after the fludrocortisone increase: sodium 139, potassium 4.4 mmol/L, creatinine 0.94 mg/dL, eGFR 112; no salt craving or edema |
| Laboratory | Plasma renin activity | After any fludrocortisone change, then at least yearly; aim for the upper normal range | Completed today | 2.6 ng/mL/h, in the upper normal range as intended |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Used correctly during influenza; injection kit replaced in date |
| Laboratory | TSH and free T4 | Confirmatory repeat 2 to 3 months after a newly abnormal TSH, before treatment (CMID); TSH at least yearly in adrenal insufficiency | Completed today | Confirmatory repeat at two months: TSH 9.2 mIU/L, free T4 0.8 ng/dL; levothyroxine started |
| Medication safety | Levothyroxine: timing, interactions, and signs of over-replacement | At the start and at each thyroid review | Completed today | Glucocorticoid replacement secure before starting; taken on an empty stomach, apart from calcium or iron |
| Laboratory | Other associated autoimmune disease: vitamin B12, A1c, and celiac serology | At diagnosis, then yearly or with symptoms | Up to date | Normal at intake; next yearly |
| Imaging | Bone density (DXA) | Once now; repeat only if risk rises | Up to date | Within the expected range at two weeks |
| Survey | Oswestry Disability Index | Each back pain review | Completed today | 26%, from 32% |
| Self-management | Exercise therapy, physical therapy, and brace use | Weekly to twice weekly physical therapy, daily home program | Completed today | Six sessions; swimming three times a week; brace for the car only |
| Medication safety | Analgesic use | Every visit | Completed today | Acetaminophen a few times a week; no NSAID or opioid |
| Referral | Endocrinology review | At diagnosis, then at least yearly | Up to date | Dr. Desai reviewed today's results by message and agreed with levothyroxine; yearly review booked |

## Goal progress

- No adrenal crisis and no emergency admission through nine months. In progress; target 2026-10-19. **S**
- Hydrocortisone at the lowest dose that keeps him well, within 15 to 25 mg a day, with his weight back toward his usual 72 kg and no signs of over-replacement. In progress; target 2026-10-19. **S**
- Sodium and potassium normal, renin in the upper normal range, and no postural drop in blood pressure by the six-week review. Outcome by 2026-03-09: Sodium 139, potassium 4.4 mmol/L; renin 2.6 ng/mL/h; no postural drop. **S**
- He can state the sick-day rules and give the emergency injection by the two-week visit. Outcome by 2026-01-26: Stated the rules and gave a practice injection on a trainer. **S**
- Oswestry Disability Index below 20% by three months, with the brace used only for long travel. In progress; target 2026-04-20. **S**

## Medication changes

- Started: Levothyroxine 50 mcg oral tablet, one tablet by mouth each morning on an empty stomach **S**

## Guideline basis

- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016), Endocrine Society (Journal of Clinical Endocrinology and Metabolism)
- Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014), American Thyroid Association (Thyroid)
- Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017), American College of Physicians (Annals of Internal Medicine)
- 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (2022), American College of Rheumatology (Arthritis and Rheumatology)
- Osteoporosis in men: an Endocrine Society clinical practice guideline (2012), Endocrine Society (Journal of Clinical Endocrinology and Metabolism)
- American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023), American College of Gastroenterology (American Journal of Gastroenterology)
- CMID: Clinical Monitoring Intelligence Database, hypothyroidism monograph (2026), Aether Forge

## Follow-up

- Review in six weeks with TSH, free T4, sodium and potassium. Follow the sick-day rules for any fever or vomiting. **S**
- Next scheduled visit 2026-04-20: six-week review after starting levothyroxine. **S**
